<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">SARS-CoV-2 virus reference sequence used for the analysis was deposited in January 2020 by Wu and coworkers [
 <xref ref-type="bibr" rid="CR11">11</xref>] formerly called “Wuhan seafood market pneumonia virus” (WSM, NC_045512) (
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NC_045512" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ncbi.nlm.nih.gov/nuccore/NC_045512</ext-link>
 <bold>)</bold>. GISAID database (
 <ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.gisaid.org/</ext-link>) filtered from December 2019 up to March 13th, 2020 was used to collect 220 SARS-CoV-2 complete genomes of different patients all around the world (i.e. China, USA, Canada, Australia, United Kingdom, Germany, France, Japan, Italy, Switzerland, Singapore, Luxembourg, Netherlands, Spain, Portugal, Sweden, Czech Republic, Thailand, India, Cambodia, Hong Kong, Finland, Singapore, and Ireland) taking into particular consideration those deposited during the development of European outbreaks. Only complete genomes (28000–30,000 bps) were analyzed.
</p>
